Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finn

Showing results (201-210 of 407) with videos related to

Pageof 41
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|August 25, 2006
Recent experience with open repair of pectus excavatum with minimal cartilage resectionEric W Fonkalsrud, Julianne Mendoza, Paul J Finn, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytesP Ciborowski, W M Konitzki, J M Blander, et al.
Annals of the New York Academy of Sciences|September 23, 2009
Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53 (-/-) miceLaura A Vella, Min Yu, Amy B Phillips, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 8, 2020
A randomized trial of the acceptability of a daily multi-allergen food supplement for infantsJane L Holl, Lucy A Bilaver, Daniel J Finn, et al.
Oncoimmunology|January 4, 2018
mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targetingJason J Lohmueller, James D Ham, Michael Kvorjak, et al.
Molecular Immunology|February 17, 2009
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancerAnn Willman Silk, Robert E Schoen, Douglas M Potter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancerPamela L Beatty, Scott E Plevy, Antonia R Sepulveda, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognitionD Bu, N Domenech, J Lewis, et al.
Paediatrics & Child Health|March 10, 2010
Allocation of health care resources in the neonatal and perinatal area -CPS Symposium 1996D McMillan, S Lee, M Serediak, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancerPamela L Beatty, Sowmya Narayanan, Jean Gariépy, et al.
Pageof 41

Showing results (201-210 of 407) with videos related to

Sort By:
Pageof 41
Archives of Surgery (Chicago, Ill. : 1960)|August 25, 2006
Recent experience with open repair of pectus excavatum with minimal cartilage resectionEric W Fonkalsrud, Julianne Mendoza, Paul J Finn, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytesP Ciborowski, W M Konitzki, J M Blander, et al.
Annals of the New York Academy of Sciences|September 23, 2009
Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53 (-/-) miceLaura A Vella, Min Yu, Amy B Phillips, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 8, 2020
A randomized trial of the acceptability of a daily multi-allergen food supplement for infantsJane L Holl, Lucy A Bilaver, Daniel J Finn, et al.
Oncoimmunology|January 4, 2018
mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targetingJason J Lohmueller, James D Ham, Michael Kvorjak, et al.
Molecular Immunology|February 17, 2009
Humoral immune response to abnormal MUC1 in subjects with colorectal adenoma and cancerAnn Willman Silk, Robert E Schoen, Douglas M Potter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancerPamela L Beatty, Scott E Plevy, Antonia R Sepulveda, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognitionD Bu, N Domenech, J Lewis, et al.
Paediatrics & Child Health|March 10, 2010
Allocation of health care resources in the neonatal and perinatal area -CPS Symposium 1996D McMillan, S Lee, M Serediak, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancerPamela L Beatty, Sowmya Narayanan, Jean Gariépy, et al.
Pageof 41